Follicular Flushing Using Double Lumen Needle Versus Direct Aspiration in Low Prognosis Patients According to the POSEIDON Criteria
FLUSHING
1 other identifier
interventional
40
1 country
1
Brief Summary
This is a prospective, randomized, controlled clinical trial designed to evaluate whether follicular flushing increases the number of cumulus-oocyte complexes (COCs) retrieved compared to single aspiration in patients with poor ovarian response belonging to Poseidon groups 3 and 4. A total of 40 patients with poor ovarian response belonging to Poseidon groups 3 and 4 will be included. In each patient, one ovary will be randomized to the study technique (follicular flushing), and the other ovary will be randomized to the control technique (single aspiration).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2025
CompletedFirst Posted
Study publicly available on registry
December 8, 2025
CompletedStudy Start
First participant enrolled
January 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedApril 14, 2026
April 1, 2026
3 months
November 17, 2025
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of cumulus-oocyte complexes
number of cumulus-oocyte complexes (COCs) retrieved after each aspiration
During the egg retrieval
Secondary Outcomes (4)
Oocyte recovery rate
day of the egg retrieval
Fertilization rate
1 day after the egg retrieval
Empty follicle rate
day of the egg retrieval
Procedure time
In seconds from needle insertion to its withdrawal for each ovary
Study Arms (2)
Single Aspiration Arm
ACTIVE COMPARATOROocytes will be retrieved from one ovary using single follicular aspiration
Follicular Flushing Arm
EXPERIMENTALOocytes will be retrieved from the contralateral ovary using follicular flushing, with up to three flushes per follicle if no cumulus-oocyte complex is obtained initially
Interventions
Follicles will be aspirated using 17G needles of the same gauge in both groups. For follicular flushing, the same type of needle used for single aspiration (Cook) will be employed. To eliminate dead space, the needle will be prefilled with flushing medium before starting the procedure. Aspiration pressure will be maintained at 190 mmHg during oocyte retrieval. In the follicular flushing group, if no cumulus-oocyte complex (COC) is recovered during the initial aspiration, follicular flushing will be performed until a COC is obtained, up to a maximum of three times. After three flushes, if no COC is retrieved, the procedure will be completed by rinsing with flushing medium to minimize the possibility of oocyte retention within the needle.
In the single aspiration group, after aspirating all follicles, the needle will be rinsed with flushing medium to prevent the possibility of oocyte retention within the needle.
Eligibility Criteria
You may qualify if:
- Pacientes con baja respuesta ovárica grupos POSEIDON 3 y 4 (\< 35 años y RFA \<5 y/o AMH \< 1.2 ng/ml o \> 35 años≥ 35 años y RFA \<5 o AMH \<1.2 ng/mL respectivamente)
- Pacientes menores o igual a 43 años.
- Índice de Masa Corporal (IMC) de 18-35 kg/m2
- Estimulación ovárica para ICSI
- Presencia y accesibilidad de ambos ovarios.
- Ausencia de patología ovárica
- Cuando se cumplan los criterios de desencadenamiento para la maduración final del ovocito, cada ovario debe contener al menos un folículo mayor o igual a 14 mm.
- Haber dado su consentimiento por escrito.
You may not qualify if:
- Presence of a single ovary.
- Presence of ovarian pathology.
- Use of conventional IVF as the fertilization method.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Instituto Bernabeu
Alicante, Alicante, 03016, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
November 17, 2025
First Posted
December 8, 2025
Study Start
January 1, 2026
Primary Completion
April 1, 2026
Study Completion
April 1, 2026
Last Updated
April 14, 2026
Record last verified: 2026-04